Why the study?
Does bivalirudin reduce adverse clinical outcomes and major bleeding compared to heparin with provisional or routine GPI in adults undergoing PCI for angina or ACS?
Population
44,088 adults aged 18 years or older diagnosed with angina or acute coronary syndrome undergoing…
Comparison
Bivalirudin-based regimens during PCI. vs Heparin-based regimens with either provisional…
Design
Meta-analysis
Follow-up
30 days
Authors
Loading...
Highlights a critical bleeding-versus-ischemia trade-off during PCI; confirms the need.
Does bivalirudin reduce adverse clinical outcomes and major bleeding compared to heparin with provisional or routine GPI in adults undergoing PCI for angina or ACS?
Bivalirudin during PCI reduces major bleeding but increases the risk of stent thrombosis compared to heparin regimens, highlighting a trade-off between bleeding and ischemic risks.
Hamdi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: